Emergent BioSolutions Wins $4.9M Anthrax Vaccine Grant – Bizjournals.com

 Emergent BioSolutions wins $4.9M anthrax vaccine grant   Bizjournals.com
Emergent BioSolutions wins $4.9M anthrax vaccine grant
Bizjournals.com
Rockville based Emergent announced Wednesday that it had been awarded $4.9 million over two years from the National Institute of Allergy and Infectious
EBS: Awarded $4.9M Funding from NIAID for Development of Anthrax Trading Markets (press release)

all 14 news articles »


Comments are closed.